Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Association of elevated pulmonary artery systolic pressure with hematologic progression in myeloproliferative neoplasms.

View Full Paper
Ask AI
Bookmark
Share

Authors

OLOrly LeivaUniversity of KentuckySSSteven SooUniversity of KentuckyCHChi-Joan HowBrigham and Women's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Leiva et al. (2024) studied this question.

synapsesocial.com/papers/68e66dd2b6db6435875f9233https://doi.org/10.1200/jco.2024.42.16_suppl.6575
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A67-05 Pulmonary Hypertension Risk Is Associated With Shortened Survival in Essential Thrombocythemia2026
  2. 2Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms2025 · 13 citations
  3. 3Incidence, risk factors, and prognostic implications of hospitalizations for heart failure among patients with myeloproliferative neoplasms2026
  4. 4The Current Landscape of Pulmonary Hypertension in Myeloproliferative Neoplasms2026
  5. 5Progression of pulmonary arterial systolic pressure after chemotherapy is a poor prognostic factor in patients with multiple myeloma2025